Drug test for qualitative analysis of cells expressing the TdT antigen - Vietnam Registration 2403157ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug test for qualitative analysis of cells expressing the TdT antigen in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403157ĐKLH/BYT-HTTB and manufactured by Becton, Dickinson and Company, BD Biosciences. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN BECTON DICKINSON ASIA LIMITED TẠI THÀNH PHỐ HỒ CHÍ MINH.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Immunotech SAS, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403157ĐKLH/BYT-HTTB
000.00.04.G18-220616-0014
BD Anti-TdT (E17-1519) APC
332791
Technical Details
Anti-TdT (E17-1519) is used for in vitro diagnosis to determine cells expressing the TdT antigen in peripheral blood, using the BD FACSLyric™ flow cytometry system. Clinical Applications: Expression of the TdT antigen in the characteristic description of individuals with or suspected of having acute blood cancer. Anti-TdT (E17-1519) is a qualitative test reagent intended for use only in laboratories.
Dates and Status
Nov 02, 2024